Pfizer Corporation - היקף יתרות המזומנים של החברה PFE

The industry is undergoing a stage of cyclical transformation, and Pfizer Inc. (PFE) is currently seeking a foothold following the decline in COVID-related sales. A diversified portfolio of oncology and rare disease medications provides stability, while strong patents guarantee high margins for innovations. The company's cash reserves demonstrate current liquidity, with the parameter reaching 14.37, confirming the holding's financial resilience.
פילוחים אנליטיים ודוחות נתונים של חברת Pfizer Inc (PFE)

This metric measures the volume of immediate liquidity, reflecting the aggregate of highly liquid assets used to ensure operational resilience. By analyzing the cash history of Pfizer Inc. (PFE), an investor assesses the company's ability to fund aggressive acquisitions of new biopharmaceutical assets. A sufficient capital buffer confirms the issuer's solvency during the transformation of its product portfolio. The current level of reserves guarantees financial stability during the implementation of management's long-term strategy.